These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7229004)

  • 1. Cultural and biochemical characteristics of clinical isolates of unusual colistin-resistant pseudomonads.
    Oberhofer TR
    J Clin Microbiol; 1980 Aug; 12(2):156-60. PubMed ID: 7229004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of human isolates of unidentified fluorescence pseudomonads capable of growth at 42 degrees C.
    Oberhofer TR
    J Clin Microbiol; 1981 Nov; 14(5):492-5. PubMed ID: 7309846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognition of Pseudomonas pickettii in the clinical laboratory: biochemical characterization of 62 strains.
    Riley PS; Weaver RE
    J Clin Microbiol; 1975 Jan; 1(1):61-4. PubMed ID: 1176593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assignment of CDC weak oxidizer group 2 (WO-2) to the genus Pandoraea and characterization of three new Pandoraea genomospecies.
    Daneshvar MI; Hollis DG; Steigerwalt AG; Whitney AM; Spangler L; Douglas MP; Jordan JG; MacGregor JP; Hill BC; Tenover FC; Brenner DJ; Weyant RS
    J Clin Microbiol; 2001 May; 39(5):1819-26. PubMed ID: 11325997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colistin susceptibility test evaluation of multiple-resistance-level Pseudomonas aeruginosa isolates generated in a morbidostat device.
    Javed M; Ueltzhoeffer V; Heinrich M; Siegrist HJ; Wildermuth R; Lorenz FR; Neher RA; Willmann M
    J Antimicrob Chemother; 2018 Dec; 73(12):3368-3374. PubMed ID: 30137346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of fluorescent pseudomonads by their effect on milk agar.
    Reynolds MT; Falkiner FR; Hardy R; Keane CT
    J Med Microbiol; 1979 Aug; 12(3):379-82. PubMed ID: 112257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic characterization and colistin susceptibilities of carbapenem-resistant of Pseudomonas aeruginosa and Acinetobacter spp.
    Mohanty S; Maurya V; Gaind R; Deb M
    J Infect Dev Ctries; 2013 Nov; 7(11):880-7. PubMed ID: 24240048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superior activity of colistin against Pseudomonas aeruginosa clinical isolates, including multidrug-resistant isolates, from multiple infection sources from 2007 to 2009.
    Hawser SP
    Int J Antimicrob Agents; 2011 Jun; 37(6):587. PubMed ID: 21493045
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pseudomonas maltophilia as an agent of infection in man (author's transl)].
    Fritsche D; Lütticken R; Böhmer H
    Zentralbl Bakteriol Orig A; 1974; 229(1):89-97. PubMed ID: 4155214
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Ceftolozane-Tazobactam in Combination with Colistin against Extensively Drug-Resistant Pseudomonas aeruginosa, Including High-Risk Clones, in an
    Montero M; Domene Ochoa S; López-Causapé C; VanScoy B; Luque S; Sorlí L; Campillo N; Angulo-Brunet A; Padilla E; Prim N; Pomar V; Rivera A; Grau S; Ambrose PG; Oliver A; Horcajada JP
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32041712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic variations between colistin-susceptible and -resistant Pseudomonas aeruginosa clinical isolates and their effects on colistin resistance.
    Lee JY; Na IY; Park YK; Ko KS
    J Antimicrob Chemother; 2014 May; 69(5):1248-56. PubMed ID: 24474431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of colistin combined with doripenem at clinically relevant concentrations against multidrug-resistant Pseudomonas aeruginosa in an in vitro dynamic biofilm model.
    Lora-Tamayo J; Murillo O; Bergen PJ; Nation RL; Poudyal A; Luo X; Yu HY; Ariza J; Li J
    J Antimicrob Chemother; 2014 Sep; 69(9):2434-42. PubMed ID: 24833752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas vesicularis from cervical specimens.
    Otto LA; Deboo BS; Capers EL; Pickett MJ
    J Clin Microbiol; 1978 Apr; 7(4):341-5. PubMed ID: 567655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDC group O-3: phenotypic characteristics, fatty acid composition, isoprenoid quinone content, and in vitro antimicrobic susceptibilities of an unusual gram-negative bacterium isolated from clinical specimens.
    Daneshvar MI; Hill B; Hollis DG; Moss CW; Jordan JG; Macgregor JP; Tenover F; Weyant RS
    J Clin Microbiol; 1998 Jun; 36(6):1674-8. PubMed ID: 9620398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of Pseudomonas aeruginosa isolates resistant to all antimicrobial agents, but susceptible to colistin, in Daegu, Korea.
    Lee YC; Ahn BJ; Jin JS; Kim JU; Lee SH; Song DY; Lee WK; Lee JC
    J Microbiol; 2007 Aug; 45(4):358-63. PubMed ID: 17846591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of nonclonal Pseudomonas aeruginosa isolates with reduced colistin susceptibility in Korea.
    Lee JY; Song JH; Ko KS
    Microb Drug Resist; 2011 Jun; 17(2):299-304. PubMed ID: 21381965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance and Heteroresistance to Colistin in Pseudomonas aeruginosa Isolates from Wenzhou, China.
    Lin J; Xu C; Fang R; Cao J; Zhang X; Zhao Y; Dong G; Sun Y; Zhou T
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro efficacy of colistin against multi-drug resistant Pseudomonas aeruginosa by minimum inhibitory concentration.
    Gill MM; Rao JU; Kaleem F; Hassan A; Khalid A; Anjum R
    Pak J Pharm Sci; 2013 Jan; 26(1):7-10. PubMed ID: 23261721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of colistin resistance in Pseudomonas aeruginosa ST235 clone in South Korea.
    Wi YM; Choi JY; Lee JY; Kang CI; Chung DR; Peck KR; Song JH; Ko KS
    Int J Antimicrob Agents; 2017 Jun; 49(6):767-769. PubMed ID: 28392440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.